Table 2.

Characteristics of five patients who received a haploidentical stem cell transplant at UTMDACC and had donor-specific anti-HLA antibodies.

Patient #	1	2	3	4	5
Age	43	37	26	39	50
Gender	F	F	F	F	F
Diagnosis	AML	AML	AML	AML	AML
% BM blasts at transplant	0	13	1	23	4
Donor	Sib	Sib	Sib	Son	Daughter
# HLA mismatches*	3	4	2	5	2
Cell type	PB	PB	PB	PB	PB
# CD34+ cells infused (×10e6/kg)	14.8	6.6	17.5	17.5	9.4
# Pregnancies	0	3	3	2	3
# PRBCs transfused prior to transplant	37	41	17	65	32

F- female; AML – acute myeloid leukemia; BM – bone marrow; Sib – sibling; PB – peripheral blood; PRBCs – packed red blood cells;

^*Number of allele mismatches in HLA A, B, C, DRB1, DQB1 loci